TOI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Oncology Institute Inc (TOI).


$150.45M Market Cap.

As of 03/28/2024 5:00 PM ET (MRY) • Disclaimer

TOI Market Cap. (MRY)


TOI Shares Outstanding (MRY)


TOI Assets (MRY)


Total Assets

$209.24M

Total Liabilities

$152.22M

Total Investments

$49.37M

TOI Income (MRY)


Revenue

$324.24M

Net Income

-$67.88M

Operating Expense

$136.59M

TOI Cash Flow (MRY)


CF Operations

-$36.31M

CF Investing

$62.64M

CF Financing

-$6.85M

TOI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

-

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

-

-

0%

-

TOI Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$209,240,000 (-20.04%)

$261,665,000 (28.62%)

$203,439,000 (209.70%)

$65,689,000 (10.36%)

Assets Current

$143,493,000 (10.03%)

$130,418,000 (-15.34%)

$154,056,000 (418.36%)

$29,720,000 (36.38%)

Assets Non-Current

$65,747,000 (-49.91%)

$131,247,000 (165.77%)

$49,383,000 (37.29%)

$35,969,000 (-4.66%)

Goodwill & Intangible Assets

$25,134,000 (-36.17%)

$39,375,000 (-12.25%)

$44,871,000 (32.98%)

$33,743,000 (-6.48%)

Shareholders Equity

$57,025,000 (-53.70%)

$123,175,000 (18.26%)

$104,159,000 (270.66%)

$28,101,000 (574.60%)

Property Plant & Equipment Net

$40,052,000 (21.22%)

$33,041,000 (688.19%)

$4,192,000 (99.24%)

$2,104,000 (35.66%)

Cash & Equivalents

$33,488,000 (139.03%)

$14,010,000 (-87.84%)

$115,174,000 (1820.21%)

$5,998,000 (145.20%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$49,367,000 (-58.22%)

$118,150,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$49,367,000 (-17.44%)

$59,796,000 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$58,354,000 (0%)

$0 (0%)

$0 (0%)

Inventory

$13,678,000 (47.69%)

$9,261,000 (43.85%)

$6,438,000 (47.86%)

$4,354,000 (11.96%)

Trade & Non-Trade Receivables

$42,911,000 (6.13%)

$40,433,000 (90.33%)

$21,244,000 (23.09%)

$17,259,000 (17.13%)

Trade & Non-Trade Payables

$14,429,000 (53.96%)

$9,372,000 (-39.76%)

$15,559,000 (23.06%)

$12,643,000 (42.29%)

Accumulated Retained Earnings (Deficit)

-$146,150,000 (-131.68%)

-$63,082,000 (0.24%)

-$63,234,000 (-20.89%)

-$52,307,000 (-769.61%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$32,000 (-91.18%)

$363,000 (-27.83%)

$503,000 (-81.76%)

$2,757,000 (-19.98%)

Total Debt

$119,675,000 (10.63%)

$108,179,000 (59014.21%)

$183,000 (-98.47%)

$11,929,000 (0%)

Debt Current

$6,363,000 (15.73%)

$5,498,000 (2904.37%)

$183,000 (-96.59%)

$5,368,000 (0%)

Debt Non-Current

$113,312,000 (10.35%)

$102,681,000 (0%)

$0 (0%)

$6,561,000 (0%)

Total Liabilities

$152,215,000 (9.91%)

$138,490,000 (39.49%)

$99,280,000 (164.13%)

$37,588,000 (117.29%)

Liabilities Current

$34,788,000 (17.05%)

$29,720,000 (-0.26%)

$29,798,000 (4.16%)

$28,607,000 (110.57%)

Liabilities Non-Current

$117,427,000 (7.96%)

$108,770,000 (56.54%)

$69,482,000 (673.66%)

$8,981,000 (141.88%)

TOI Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$324,239,000 (28.42%)

$252,483,000 (24.37%)

$203,003,000 (8.26%)

$187,515,000 (20.66%)

Cost of Revenue

$264,666,000 (32.08%)

$200,390,000 (23.58%)

$162,155,000 (7.65%)

$150,636,000 (20.06%)

Selling General & Administrative Expense

$113,851,000 (-4.88%)

$119,689,000 (43.57%)

$83,365,000 (98.97%)

$41,898,000 (41.34%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$136,591,000 (1.90%)

$134,044,000 (54.60%)

$86,706,000 (92.36%)

$45,076,000 (38.33%)

Interest Expense

$6,777,000 (66.02%)

$4,082,000 (1175.63%)

$320,000 (-7.78%)

$347,000 (10181.48%)

Income Tax Expense

-$36,000 (85.19%)

-$243,000 (63.79%)

-$671,000 (-36.11%)

-$493,000 (-135.64%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$83,068,000 (-54750.00%)

$152,000 (101.39%)

-$10,927,000 (23.70%)

-$14,322,000 (-256.15%)

Net Income to Non-Controlling Interests

-$15,191,000 (-18184.52%)

$84,000 (128.09%)

-$299,000 (0%)

$0 (0%)

Net Income

-$67,877,000 (-99919.12%)

$68,000 (100.64%)

-$10,628,000 (25.79%)

-$14,322,000 (-256.15%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$67,877,000 (-99919.12%)

$68,000 (100.64%)

-$10,628,000 (25.79%)

-$14,322,000 (-256.15%)

Weighted Average Shares

$73,748,660 (1.31%)

$72,793,497 (9.91%)

$66,230,606 (12.03%)

$59,117,723 (491.18%)

Weighted Average Shares Diluted

$73,748,660 (-8.51%)

$80,605,600 (21.70%)

$66,230,606 (12.03%)

$59,117,723 (491.18%)

Earning Before Interest & Taxes (EBIT)

-$61,136,000 (-1664.78%)

$3,907,000 (135.59%)

-$10,979,000 (24.12%)

-$14,468,000 (-449.12%)

Gross Profit

$59,573,000 (14.36%)

$52,093,000 (27.53%)

$40,848,000 (10.76%)

$36,879,000 (23.17%)

Operating Income

-$77,018,000 (6.02%)

-$81,951,000 (-78.71%)

-$45,858,000 (-459.45%)

-$8,197,000 (-209.93%)

TOI Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$62,640,000 (147.59%)

-$131,614,000 (-982.89%)

-$12,154,000 (-37.43%)

-$8,844,000 (-634.21%)

Net Cash Flow from Financing

-$6,847,000 (-107.43%)

$92,206,000 (-40.13%)

$154,010,000 (1195.51%)

$11,888,000 (655447.30%)

Net Cash Flow from Operations

-$36,315,000 (41.20%)

-$61,756,000 (-88.97%)

-$32,680,000 (-6533.07%)

$508,000 (-85.95%)

Net Cash Flow / Change in Cash & Cash Equivalents

$19,478,000 (119.25%)

-$101,164,000 (-192.66%)

$109,176,000 (2973.65%)

$3,552,000 (47.45%)

Net Cash Flow - Business Acquisitions and Disposals

-$4,456,000 (48.05%)

-$8,577,000 (7.84%)

-$9,307,000 (-6104.67%)

-$150,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$71,663,000 (160.99%)

-$117,508,000 (0%)

$0 (0%)

-$7,500,000 (0%)

Capital Expenditure

-$4,567,000 (17.40%)

-$5,529,000 (-94.20%)

-$2,847,000 (-138.44%)

-$1,194,000 (0.88%)

Issuance (Repayment) of Debt Securities

-$3,370,000 (-103.33%)

$101,270,000 (13069.05%)

$769,000 (-93.69%)

$12,181,000 (671599.45%)

Issuance (Purchase) of Equity Shares

-$893,000 (89.03%)

-$8,142,000 (-102.44%)

$333,946,000 (667792.00%)

$50,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$17,810,000 (-35.66%)

$27,683,000 (12.83%)

$24,535,000 (16148.34%)

$151,000 (60.63%)

Depreciation Amortization & Accretion

$5,873,000 (33.14%)

$4,411,000 (32.03%)

$3,341,000 (5.13%)

$3,178,000 (8.03%)

TOI Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

18.40% (-10.68%)

20.60% (2.49%)

20.10% (2.03%)

19.70% (2.07%)

Profit Margin

-20.90% (0%)

0% (0%)

-5.20% (31.58%)

-7.60% (-192.31%)

EBITDA Margin

-17.00% (-615.15%)

3.30% (186.84%)

-3.80% (36.67%)

-6.00% (-3100.00%)

Return on Average Equity (ROAE)

-87.00% (-87100.00%)

0.10% (100.62%)

-16.10% (87.89%)

-132.90%

Return on Average Assets (ROAA)

-30.40% (0%)

0% (0%)

-7.90% (-5.33%)

-7.50%

Return on Sales (ROS)

-18.90% (-1360.00%)

1.50% (127.78%)

-5.40% (29.87%)

-7.70% (-352.94%)

Return on Invested Capital (ROIC)

-24.00% (-1100.00%)

2.40% (102.52%)

-95.30% (-1048.19%)

-8.30%

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-2.22

-

-60.94 (-35.42%)

-45

Price to Sales Ratio (P/S)

0.46 (-2.52%)

0.48 (-85.04%)

3.18 (-6.58%)

3.4

Price to Book Ratio (P/B)

2.64 (172.24%)

0.97 (-85.87%)

6.86 (-37.94%)

11.05

Debt to Equity Ratio (D/E)

2.67 (137.46%)

1.12 (17.94%)

0.95 (-28.77%)

1.34 (145.79%)

Earnings Per Share (EPS)

-0.92 (0%)

0 (0%)

-0.16 (33.33%)

-0.24 (99.94%)

Sales Per Share (SPS)

4.4 (26.79%)

3.47 (13.15%)

3.06 (-3.37%)

3.17 (-79.59%)

Free Cash Flow Per Share (FCFPS)

-0.55 (40.04%)

-0.92 (-72.39%)

-0.54 (-4366.67%)

-0.01 (-104.98%)

Book Value Per Share (BVPS)

0.77 (-54.31%)

1.69 (7.57%)

1.57 (231.16%)

0.47 (180.24%)

Tangible Assets Book Value Per Share (TABVPS)

2.5 (-18.27%)

3.05 (27.57%)

2.39 (343.33%)

0.54 (-76.96%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (-109.52%)

42 (165.63%)

-64 (-204.76%)

-21

Enterprise Value Over EBITDA (EV/EBITDA)

-4.35 (-122.05%)

19.72 (121.39%)

-92.16 (-236.16%)

-27.41

Asset Turnover

1.45 (35.63%)

1.07 (-28.96%)

1.51 (53.04%)

0.99

Current Ratio

4.13 (-5.99%)

4.39 (-15.13%)

5.17 (397.59%)

1.04 (-35.22%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$40,882,000 (39.24%)

-$67,285,000 (-89.39%)

-$35,527,000 (-5078.86%)

-$686,000 (-128.46%)

Enterprise Value (EV)

$240,259,917 (46.50%)

$163,998,784 (-76.70%)

$703,887,302 (127.43%)

$309,501,429

Earnings Before Tax (EBT)

-$67,913,000 (-38707.43%)

-$175,000 (98.45%)

-$11,299,000 (23.73%)

-$14,815,000 (-461.57%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$55,263,000 (-764.38%)

$8,318,000 (208.90%)

-$7,638,000 (32.35%)

-$11,290,000 (-3776.22%)

Invested Capital

$235,505,000 (-17.87%)

$286,739,000 (1980.99%)

$13,779,000 (48.64%)

$9,270,000 (25.11%)

Working Capital

$108,705,000 (7.95%)

$100,698,000 (-18.96%)

$124,258,000 (11064.24%)

$1,113,000 (-86.44%)

Tangible Asset Value

$184,106,000 (-17.18%)

$222,290,000 (40.19%)

$158,568,000 (396.36%)

$31,946,000 (36.28%)

Market Capitalization

$150,447,917 (26.04%)

$119,363,784 (-83.29%)

$714,178,160 (130.01%)

$310,500,000

Average Equity

$78,000,500 (-38.47%)

$126,772,500 (91.70%)

$66,130,000 (513.72%)

$10,775,256

Average Assets

$223,046,250 (-5.26%)

$235,429,750 (74.96%)

$134,564,000 (-29.21%)

$190,098,676

Invested Capital Average

$255,091,250 (59.13%)

$160,308,250 (1291.02%)

$11,524,500 (-93.41%)

$174,912,032

Shares

73,748,979 (1.95%)

72,341,687 (-1.24%)

73,249,042 (154.78%)

28,750,000 (0.00%)